Pharmacokinetics of esomeprazole are not affected by age: An assessment in the elderly
Göran Hasselgren(AstraZeneca (Sweden)), Kerstin Röhss(AstraZeneca (Sweden)), Lars‐Göran Nilsson(Stockholm University), Catharina Claar-Nilsson, Tommy Andersson(Karolinska University Hospital), Mohammed Hassan‐Alin(AstraZeneca (United Kingdom))
Cited by 3
Related Papers
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175
Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
|Molecular Pharmacology|1986|160
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
|British Journal of Clinical Pharmacology|1998|124
A Formylated Hexapeptide Ligand Mimics the Ability of Wnt-5a to Impair Migration of Human Breast Epithelial Cells
|Journal of Biological Chemistry|2005|115